New York · 2025 Regular Session · Bill

A 9010: Requires practitioners to discuss certain risks with a patient who is being prescribed a controlled substance or an opioid analgesic

In committee Last action May 4, 2026: PRINT NUMBER 9010B

Plain-language summary

A 9010 is a bill introduced in the New York House on August 13, 2025. According to its official title, it concerns: Requires practitioners to discuss certain risks with a patient who is being prescribed a controlled substance or an opioid analgesic. Primary sponsor: Linda Rosenthal (Democratic). It lists 6 additional sponsors. Most recent recorded action (May 4, 2026): PRINT NUMBER 9010B.

Sponsors

Primary sponsor: Linda Rosenthal (Democratic). 6 co-sponsors.